M
Marianna Sirico
Researcher at Imperial College London
Publications - 15
Citations - 181
Marianna Sirico is an academic researcher from Imperial College London. The author has contributed to research in topics: Everolimus & Breast cancer. The author has an hindex of 4, co-authored 15 publications receiving 46 citations. Previous affiliations of Marianna Sirico include Catholic University of the Sacred Heart & Concordia University Wisconsin.
Papers
More filters
Journal ArticleDOI
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.
Daniele Generali,Giancarlo Bosio,Fabio Malberti,Antonio Cuzzoli,Sophie Testa,Laura Romanini,Antonio Fioravanti,Alessandro Morandini,Luca Pianta,Guglielmo Giannotti,Erika Maria Viola,Matteo Giorgi-Pierfranceschi,Marina Foramitti,Rosa Angela Tira,Ilaria Zangrandi,Giulia Chiodelli,Andrea Machiavelli,Maria Rosa Cappelletti,Alessia Giossi,Valeria De Giuli,Chiara Costanzi,Chiara Campana,Ottavia Bernocchi,Marianna Sirico,Alessia Zoncada,Alfredo Molteni,Sergio Venturini,Fabiola Giudici,Maurizio Scaltriti,Angelo Pan +29 more
TL;DR: In this article, the authors examined the efficacy and safety of canakinumab in patients with moderate COVID-19-related pneumonia and found significant clinical improvement in ventilation regimes.
Journal ArticleDOI
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
Francesco Schettini,Francesco Schettini,Fabiola Giudici,Ottavia Bernocchi,Marianna Sirico,Silvia Paola Corona,Mario Giuliano,Mariavittoria Locci,Ida Paris,Giovanni Scambia,Sabino De Placido,Pasquale Rescigno,Aleix Prat,Giuseppe Curigliano,Daniele Generali +14 more
TL;DR: In this article, the role of PARPis in the treatment of metastatic solid tumours, with and without BRCA1/2 mutations, was investigated using a random-effects model.
Journal ArticleDOI
Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects.
TL;DR: In this paper, the authors discuss the latest clinical data from clinical trials for immune-checkpoint inhibitors for the treatment of hepatocellular carcinoma (HCC) in a mini-review.
Journal ArticleDOI
Advances in anti-BRAF therapies for lung cancer
Giandomenico Roviello,Alberto D'Angelo,Marianna Sirico,Matteo Pittacolo,Felipe Umpierre Conter,Navid Sobhani +5 more
TL;DR: In this paper, the authors describe changes in the landscape of BRAF-mutated lung cancer treatment and analyze insights from major clinical trials in the context of future therapeutic prospects, and analyze the potential of anti-BRAF therapies in NSCLC treatment.
Journal ArticleDOI
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.
TL;DR: An overview of the most recent and significant field of application of insulin-like growth factor-1 inhibitors and relevant therapeutic strategies, weighing their possible future impact on clinical practice can be found in this paper.